Elanco Animal Health Incorporated Income Taxes Paid
Elanco Animal Health Incorporated (ELAN) reported Income Taxes Paid of $225.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-24
- Elanco Animal Health Incorporated income taxes paid, net for fiscal 2025 was $225.00M, a 60.71% increase from fiscal 2024.
- Elanco Animal Health Incorporated income taxes paid, net for fiscal 2024 was $140.00M, a 47.37% increase from fiscal 2023.
- Elanco Animal Health Incorporated income taxes paid, net for fiscal 2023 was $95.00M, a 2.15% increase from fiscal 2022.
- Elanco Animal Health Incorporated income taxes paid, net for fiscal 2022 was $93.00M, a 38.41% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|
| 2025-12-31 | $225.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $140.00M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $95.00M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $93.00M 10-K · filed 2025-02-25 | |
| 2021-12-31 | $151.00M 10-K · filed 2024-02-26 | |
| 2020-12-31 | $97.00M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $43.00M 10-K · filed 2022-02-28 | $42.50M 10-K · filed 2020-02-28 |
| 2018-12-31 | $26.90M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $35.70M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $53.60M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |